Centaurus Financial Inc. Sells 36 Shares of The Cigna Group (NYSE:CI)

Centaurus Financial Inc. reduced its holdings in The Cigna Group (NYSE:CI) by 1.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,445 shares of the health services provider’s stock after selling 36 shares during the quarter. Centaurus Financial Inc.’s holdings in The Cigna Group were worth $847,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Larson Financial Group LLC raised its position in The Cigna Group by 56.3% in the 3rd quarter. Larson Financial Group LLC now owns 261 shares of the health services provider’s stock valued at $90,000 after purchasing an additional 94 shares during the last quarter. Kingsview Wealth Management LLC raised its holdings in shares of The Cigna Group by 2.9% in the third quarter. Kingsview Wealth Management LLC now owns 31,572 shares of the health services provider’s stock valued at $10,938,000 after buying an additional 886 shares during the last quarter. Cerity Partners LLC lifted its position in The Cigna Group by 23.9% during the 3rd quarter. Cerity Partners LLC now owns 108,520 shares of the health services provider’s stock worth $37,596,000 after buying an additional 20,926 shares in the last quarter. Great Valley Advisor Group Inc. lifted its position in The Cigna Group by 3.5% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 8,227 shares of the health services provider’s stock worth $2,850,000 after buying an additional 279 shares in the last quarter. Finally, Nicolet Advisory Services LLC grew its holdings in The Cigna Group by 13.5% during the 3rd quarter. Nicolet Advisory Services LLC now owns 882 shares of the health services provider’s stock worth $300,000 after acquiring an additional 105 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Stock Performance

Shares of NYSE:CI opened at $332.73 on Tuesday. The company has a market capitalization of $92.55 billion, a price-to-earnings ratio of 31.39, a P/E/G ratio of 0.99 and a beta of 0.51. The firm’s 50 day simple moving average is $334.74 and its 200 day simple moving average is $338.63. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $370.83.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion for the quarter, compared to analysts’ expectations of $59.58 billion. During the same period last year, the firm posted $6.77 earnings per share. The business’s quarterly revenue was up 29.8% compared to the same quarter last year. As a group, sell-side analysts forecast that The Cigna Group will post 28.5 earnings per share for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a $1.40 dividend. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.68%. The Cigna Group’s dividend payout ratio (DPR) is currently 52.83%.

Analyst Ratings Changes

A number of equities analysts have weighed in on CI shares. Barclays boosted their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Royal Bank of Canada dropped their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $394.64.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.